Shield Therapeutics(GB:STX)
GBX 3.20-0.10 (-3.03%)
GB:STX
Shield Therapeutics stock drug pipeline
GBX 3.20
At close:-0.10 (-3.03%)
Want to see GB:STX full AI Analyst Report?
Shield Therapeutics (STX) Drug Pipeline
42 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ferrous Sulfate, Ferric Maltol | Anemia, Iron-Deficiency | Phase III | Completed | Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years | Oct 27, 2021 | ― |
| Ferric Maltol Capsule, Ferric Maltol Suspension | Anemia, Iron Deficiency | Phase I | Completed | Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers | Oct 22, 2020 | ― |
| Ferric Maltol | Iron Deficiency, Anaemia In Children, Iron-Deficiency | Phase I | Completed | Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency | May 23, 2017 | ― |
| Ferric Maltol | Renal Insufficiency, Chronic, Iron-Deficiency Anemia | Phase III | Completed | Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease | Aug 30, 2016 | ― |
| Ferric Maltol, Ferric Carboxy Maltose | Crohn's Disease, Inflammatory Bowel Disease, Anemia, Iron-Deficiency | Phase III | Completed | Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD | Feb 09, 2016 | ― |
| St10 | Crohn's Disease, Iron Deficiency Anaemia, Inflammatory Bowel Disease | Phase III | Completed | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) | May 10, 2011 | ― |
| St10-021 | Ulcerative Colitis, Iron Deficiency Anaemia, Inflammatory Bowel Disease | Phase III | Completed | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | Apr 19, 2011 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Ferrous Sulfate, Ferric Maltol | Phase III | Anemia, Iron-Deficiency | Completed | Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years | Oct 27, 2021 | ― |
| Ferric Maltol Capsule, Ferric Maltol Suspension | Phase I | Anemia, Iron Deficiency | Completed | Four-Way Crossover Study to Compare Ferric Maltol Capsules and Oral Suspension in Healthy Volunteers | Oct 22, 2020 | ― |
| Ferric Maltol | Phase I | Iron Deficiency, Anaemia In Children, Iron-Deficiency | Completed | Evaluate the PK, Safety, Tolerability of Ferric Maltol at 3 Dosage Levels in Paediatric Subjects With Iron Deficiency | May 23, 2017 | ― |
| Ferric Maltol | Phase III | Renal Insufficiency, Chronic, Iron-Deficiency Anemia | Completed | Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease | Aug 30, 2016 | ― |
| Ferric Maltol, Ferric Carboxy Maltose | Phase III | Crohn's Disease, Inflammatory Bowel Disease, Anemia, Iron-Deficiency | Completed | Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD | Feb 09, 2016 | ― |
| St10 | Phase III | Crohn's Disease, Iron Deficiency Anaemia, Inflammatory Bowel Disease | Completed | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) | May 10, 2011 | ― |
| St10-021 | Phase III | Ulcerative Colitis, Iron Deficiency Anaemia, Inflammatory Bowel Disease | Completed | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1) | Apr 19, 2011 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Shield Therapeutics (GB:STX) have in its pipeline
Shield Therapeutics GB:STX is currently developing the following drugs: Ferrous Sulfate, Ferric Maltol, Ferric Maltol Capsule, Ferric Maltol Suspension, Ferric Maltol, Ferric Maltol, Ferric Carboxy Maltose, St10, St10-021. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
